|
Market Cap (5-Jun) $18,417,672 (949th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 14,697,042 |
Shortsold (2-Apr) 218 (0.00%) (630th) |
|
52w High $9.00 |
52w Low $0.300 |
P/E 14.90 |
EPS -3.21 |
MXC released this announcement to the ASX on 9 March 2021, 10:27. The announcement is not marked as price sensitive, and is 8 page(s) in length and 217.9kb in size.
You can view all announcements from MXC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MXC was 0.002% short sold according to ASIC data. It was ranked the 632nd most shorted stock on the ASX. It is now ranked as the 630th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (02 April 2024).
| Other Recent Announcements from MXC | |
|---|---|
| Details of Company Address | 30 June 2023, 17:34 |
| Company Update | 30 June 2023, 17:24 |
| Results of Meeting | 29 June 2023, 18:43 |
| Change of Director's Interest x3 | 9 March 2021, 10:27 |
| SwissPharmaCan AG increases initial purchase order | 3 March 2021, 9:31 |
| Half Yearly Report and Accounts | 26 February 2021, 13:31 |
| Notice of Meeting and Incentive Share Plan | 25 February 2021, 19:22 |
You must be logged in to post a reply.
MGC Pharmaceuticals 